Roche to Buy InterMune for $8.3B, Adds Lung Drug

Aug. 25 (Bloomberg) -- Roche is strengthening its portfolio of medicines for respiratory ailments with an agreement to buy InterMune for $8.3 billion in cash. Olivia Sterns reports on “In The Loop.” (Source: Bloomberg)
`Time Is of the Essence' for Greece to Reach Deal: Lew
23:54 - U.S. Treasury Secretary Jacob J. Lew speaks about the U.S. and global economies, Greece's debt crisis and International Monetary Fund reforms. Lew speaks at news conference at the 2015 World Bank Group/IMF Spring Meetings in Washington. (Source: Bloomberg)
  • A Penthouse Perspective on NYC Real Estate
  • Will the Comcast-Time Warner Cable Merger Ever Happen?
  • Quirky CEO: Why We Partnered With Mattel